Physician profile
Deborah Grinker
NPI 1780348961
$705.50
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $573 · 2023: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $105.55 | 2022-2023 | |
| Lilly USA, LLC | $95.69 | 2022-2023 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $94.71 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $70.62 | 2022-2023 | Verquvo, Belsomra |
| Novo Nordisk INC | $41.25 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $38.87 | 2022 | |
| Pfizer INC. | $38.37 | 2022-2023 | |
| Abbvie INC. | $32.91 | 2022 | |
| Shield Therapeutics INC | $23.65 | 2022 | |
| Amgen INC. | $19.84 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.56 | 2023 | Austedo |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.20 | 2022 | |
| Exact Sciences Corporation | $16.65 | 2023 | Cologuard Collection Kit |
| Antares Pharma, INC. | $16.58 | 2022 | |
| Xeris Pharmaceuticals, INC. | $16.16 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $15.69 | 2022 | |
| Dexcom, INC. | $15.57 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.89 | 2022 | |
| Medtronic, INC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Grinker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.